Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide
Condition(s):Multidrug Resistant TuberculosisLast Updated:April 23, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):Multidrug Resistant TuberculosisLast Updated:April 23, 2014Unknown status
Condition(s):TuberculosisLast Updated:April 13, 2017Completed
Condition(s):Tuberculosis, PulmonaryLast Updated:January 5, 2024Suspended
Condition(s):Tuberculosis; PulmonaryLast Updated:July 22, 2021Unknown status
Condition(s):Tuberculosis; Human Immunodeficiency Virus; CoinfectionLast Updated:December 7, 2023Recruiting
Condition(s):Healthy VolunteersLast Updated:April 5, 2017Completed
Condition(s):Tuberculosis Multi Drug Resistant ActiveLast Updated:September 11, 2017Withdrawn
Condition(s):Tuberculosis, Pulmonary; HIVLast Updated:January 29, 2024Recruiting
Condition(s):Pulmonary TuberculosisLast Updated:June 28, 2018Completed
Condition(s):TuberculosisLast Updated:July 26, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.